Loncar China BioPharma ETF (CHNA)

NASDAQ: CHNA · IEX Real-Time Price · USD
20.85
+1.17 (5.92%)
Jun 24, 2022 4:00 PM EDT - Market closed
5.92%
Assets $8.34M
NAV $20.85
Expense Ratio 0.79%
PE Ratio n/a
Shares Out 400,000
Dividend (ttm) $3.03
Dividend Yield 14.54%
Ex-Dividend Date Dec 29, 2021
1-Year Return -57.32%
Volume 2,772
Open 20.11
Previous Close 19.68
Day's Range 20.11 - 20.85
52-Week Low 15.75
52-Week High 49.01
Beta 0.69
Holdings 62
Inception Date Aug 14, 2018

About CHNA

The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.

Asset Class Equity
Region Asia-Pacific
Issuer Exchange Traded Concepts
Stock Exchange NASDAQ
Ticker Symbol CHNA
Index Tracked LCHINA index

Top 10 Holdings

27.14% of assets
Name Symbol Weight
Pharmaron Beijing Co Ltd Ordinary Shares - Class H n/a 3.16%
WuXi Biologics (Cayman) Inc 2269.HK 3.11%
Hangzhou Tigermed Consulting Co Ltd Class H n/a 3.00%
Wuxi AppTec Co Ltd n/a 2.77%
Kintor Pharmaceutical Ltd Ordinary Shares 9939.HK 2.65%
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H n/a 2.60%
China Resources Pharmaceutical Group Ltd Registered Shs Unitary 144A/Reg S 3320.HK 2.60%
Legend Biotech LEGN 2.50%
Akeso Inc Ordinary Shares 9926.HK 2.41%
Hansoh Pharmaceutical Group Co Ltd 3692.HK 2.33%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Dec 29, 2021 $3.0314286 Dec 31, 2021
Dec 30, 2020 $0.1546187 Jan 4, 2021
Dec 23, 2019 $0.04024942 Dec 26, 2019
Full Dividend History

News

Best Biotech Stocks & ETFs for mRNA, Gene Editing

Here is what you should know about investing in these life changing technologies.

Best-Performing ETF Areas of Last Week

Last week was slightly downbeat for Wall Street on talks of a capital gain tax hike with three big U.S. indexes remaining in the red.

Other symbols: BDRYKURETAN

4 China ETFs Beating S&P 500 in its Worst Week Since 2008

Check these China ETFs that beat the S&P 500 in the past week, which was U.S. equities?

Other symbols: CHICKFYPKWEB

Best Pharmaceutical ETFs for Q1 2020

The best pharmaceutical ETFs for Q1 2020 are KURE, CHIH, and CHNA.

Other symbols: CHIHKURE

Why These Chinese Sector ETFs Are Crushing S&P 500 in 2019

Policy easing in the Chinese economy, cooling trade tensions with the United States and Beijing's efforts for more urbanization have boosted these sector ETFs in 2019.